Andrew M. Rauth Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Ontario Cancer Institute University Health Network Biography Publications Institution JoVE Articles Andrew M. Rauth has not added a biography. If you are Andrew M. Rauth and would like to personalize this page please email our Author Liaison for assistance. Publications Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia Cancer Research. Nov, 2016 | Pubmed ID: 27758881 Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-encapsulated Doxorubicin-mitomycin C and Enable Their Spatiotemporal Co-delivery and Local Bioavailability in Breast Tumor Nanomedicine : Nanotechnology, Biology, and Medicine. Jul, 2016 | Pubmed ID: 26772427 Optimization of Controlled Release Nanoparticle Formulation of Verapamil Hydrochloride Using Artificial Neural Networks with Genetic Algorithm and Response Surface Methodology European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Aug, 2015 | Pubmed ID: 25986587 Manganese Oxide and Docetaxel Co-loaded Fluorescent Polymer Nanoparticles for Dual Modal Imaging and Chemotherapy of Breast Cancer Journal of Controlled Release : Official Journal of the Controlled Release Society. Jul, 2015 | Pubmed ID: 25908171 Optimizing the Design and in Vitro Evaluation of Bioreactive Glucose Oxidase-microspheres for Enhanced Cytotoxicity Against Multidrug Resistant Breast Cancer Cells Colloids and Surfaces. B, Biointerfaces. Jun, 2015 | Pubmed ID: 25896537 Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model Molecular Pharmaceutics. Aug, 2014 | Pubmed ID: 24830351 Matrigel Alters the Pathophysiology of Orthotopic Human Breast Adenocarcinoma Xenografts with Implications for Nanomedicine Evaluation Nanomedicine : Nanotechnology, Biology, and Medicine. Aug, 2013 | Pubmed ID: 23434679 Multifunctional Terpolymeric MRI Contrast Agent with Superior Signal Enhancement in Blood and Tumor Journal of Controlled Release : Official Journal of the Controlled Release Society. Apr, 2013 | Pubmed ID: 23353806 Doxorubicin and Mitomycin C Co-loaded Polymer-lipid Hybrid Nanoparticles Inhibit Growth of Sensitive and Multidrug Resistant Human Mammary Tumor Xenografts Cancer Letters. Jul, 2013 | Pubmed ID: 22902994 Evaluation of New Bi-functional Terpolymeric Nanoparticles for Simultaneous in Vivo Optical Imaging and Chemotherapy of Breast Cancer Drug Delivery and Translational Research. Dec, 2012 | Pubmed ID: 25787324 A Novel Nanoparticle Formulation Overcomes Multiple Types of Membrane Efflux Pumps in Human Breast Cancer Cells Drug Delivery and Translational Research. Apr, 2012 | Pubmed ID: 25786718 A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor α(v) β(3) Integrin Receptors Reveals Cyclic RGD As a Double-edged Sword Advanced Healthcare Materials. Sep, 2012 | Pubmed ID: 23184795 Thermally-triggered 'off-on-off' Response of Gadolinium-hydrogel-lipid Hybrid Nanoparticles Defines a Customizable Temperature Window for Non-invasive Magnetic Resonance Imaging Thermometry Journal of Controlled Release : Official Journal of the Controlled Release Society. Feb, 2012 | Pubmed ID: 21939700 A Novel Doxorubicin-mitomycin C Co-encapsulated Nanoparticle Formulation Exhibits Anti-cancer Synergy in Multidrug Resistant Human Breast Cancer Cells Breast Cancer Research and Treatment. Jan, 2010 | Pubmed ID: 19221875 Molecular Interactions, Internal Structure and Drug Release Kinetics of Rationally Developed Polymer-lipid Hybrid Nanoparticles Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2008 | Pubmed ID: 18406489 On the Synergistic Effect of Doxorubicin and Mitomycin C Against Breast Cancer Cells Drug Metabolism and Drug Interactions. 2007 | Pubmed ID: 18447000 Chemotherapy with Anticancer Drugs Encapsulated in Solid Lipid Nanoparticles Advanced Drug Delivery Reviews. Jul, 2007 | Pubmed ID: 17532091 Screening of Lipid Carriers and Characterization of Drug-polymer-lipid Interactions for the Rational Design of Polymer-lipid Hybrid Nanoparticles (PLN) Pharmaceutical Research. Aug, 2006 | Pubmed ID: 16850265 A New Polymer-lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-resistant Human Breast Cancer Cells Pharmaceutical Research. Jul, 2006 | Pubmed ID: 16786442 A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-lipid Hybrid Nanoparticle System The Journal of Pharmacology and Experimental Therapeutics. Jun, 2006 | Pubmed ID: 16547167 In Vitro Toxicity to Breast Cancer Cells of Microsphere-delivered Mitomycin C and Its Combination with Doxorubicin European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Apr, 2006 | Pubmed ID: 16330194 Biodegradable Dextran-based Microspheres for Delivery of Anticancer Drug Mitomycin C Biomaterials. Sep, 2005 | Pubmed ID: 15814136 Prediction of Kinetics of Doxorubicin Release from Sulfopropyl Dextran Ion-exchange Microspheres Using Artificial Neural Networks European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. Apr, 2005 | Pubmed ID: 15784330 In Vivo Efficacy and Toxicity of Intratumorally Delivered Mitomycin C and Its Combination with Doxorubicin Using Microsphere Formulations Anti-cancer Drugs. Apr, 2005 | Pubmed ID: 15746579 A New Approach to the in Vivo and in Vitro Investigation of Drug Release from Locoregionally Delivered Microspheres Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2004 | Pubmed ID: 15491816 Delivery of an Anticancer Drug and a Chemosensitizer to Murine Breast Sarcoma by Intratumoral Injection of Sulfopropyl Dextran Microspheres The Journal of Pharmacy and Pharmacology. Aug, 2003 | Pubmed ID: 12956895 नमूना निष्कर्षण और एक साथ डॉक्सोरूबिसिन और मीतोमयसीं सी के क्रोमेटोग्राफिक Quantitation ट्यूमर असर चूहों को नैनोकणों में दवा संयोजन प्रसव के बाद Rui Xue Zhang1, Tian Zhang1, King Chen1, Ji Cheng1, Paris Lai1, Andrew M. Rauth2, K. Sandy Pang1, Xiao Yu Wu1 1Department of Pharmaceutical Sciences, University of Toronto, 2Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Ontario Cancer Institute, University Health Network JoVE 56159 Cancer Research
नमूना निष्कर्षण और एक साथ डॉक्सोरूबिसिन और मीतोमयसीं सी के क्रोमेटोग्राफिक Quantitation ट्यूमर असर चूहों को नैनोकणों में दवा संयोजन प्रसव के बाद Rui Xue Zhang1, Tian Zhang1, King Chen1, Ji Cheng1, Paris Lai1, Andrew M. Rauth2, K. Sandy Pang1, Xiao Yu Wu1 1Department of Pharmaceutical Sciences, University of Toronto, 2Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Ontario Cancer Institute, University Health Network JoVE 56159 Cancer Research
